Last updated on April 21, 2014 at 7:52 EDT

Latest Non-nucleoside reverse transcriptase inhibitors Stories

2006-06-30 15:38:13

WASHINGTON (Reuters) - India's Aurobindo Pharma Ltd. won tentative U.S. approval on Friday to sell a three-in-one HIV-fighting pill, a decision that makes the drug available for purchase under a global AIDS relief plan. The Food and Drug Administration said the pill includes the active ingredients in the drugs lamivudine, zidovudine and nevirapine.

2005-12-13 17:47:26

NEW YORK (Reuters Health) - Higher blood levels of the anti-HIV drug efavirenz confer an increased risk of mental problems, Spanish researchers report. Patients with blood levels above 2.74 micrograms/milliliter were at more than five-fold greater risk of central nervous system side effects than other patients, Dr. Felix Gutierrez of the Hospital General Universitario de Elche in Alicante and colleagues report. New research suggests as many as half of patients on long-term efavirenz...

2005-07-28 13:56:49

Two new studies support the hypothesis that combination antiretroviral drug therapy may reduce the risk of mother-to-child HIV transmission through breastfeeding, findings that could have significant implications in the developing world. Researchers in the first study found mothers pass antiretroviral medications on to their breastfeeding infants in concentrations high enough to prevent infection. The second study showed levels of HIV RNA in breast milk are lower in mothers taking...